A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.

By V. Munster, Marion Koopmans, Neeltje van Doremalen, D. van Riel, E. de Wit. New England Journal of Medicine, 2020

1,273 citations recorded by the source corpus.

A Novel Coronavirus Emerging in China A novel coronavirus, designated as 2019-nCoV, emerged in Wuhan, China, at the end of 2019. Although many details of the emergence of this virus remain unknown,...

Subfields: Infectious Diseases, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/898a3a3918a808548439704d2042644b865c9945

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

In Public Health, Environmental and Occupational Health

Citations in the corpus

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges (2020, neutral): “s p p m m o o t p 2 c i y t d n n r t r b I o s t t t h [ t s s n for a pandemic [5 , 10 , 13] .”
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (2020, background): “At present, it is unknown whether the sequence similarities between SARS-CoV-2 and SARS-CoV translate into similar biological properties, including pandemic potential (Munster et al., 2020).”
Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography (2020, background): “The outbreak of the 2019 novel coronavirus (SARS-CoV-2) began in early December of 2019 (Munster et al., 2020; Wang et al., 2020).”
Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review (2020, neutral): “Progression, n (%) 1 (25) 0 (0) 0 (0) 7 (88) 4 (31) Stable, n (%) 1 (25) [Patient had normal CT at presentation] 0 (0) 0 (0) 1 (13) [Patient with normal CT] 2 (15)”
Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses (2020, background): “Table 1 gives estimates of case fatality rate as well as R0 value of several commonly known emerging virus infections based on data collected from literatures [16,17], WHO and CDC.”
Coronavirus Infections in Children Including COVID-19 (2020, background): “It caused severe lower respiratory tract infection with a severe morbidity and a high case-fatality rate (approaching 50% in individuals over 60 years of age, overall 10%).(63,106,107,126) Person-toperson transmission of SARS-CoV is well established.”
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia (2020, background): “In recent days, infections have been identified in other Chinese cities and in more than a dozen countries around the world.(5) Here, we provide an analysis of data on the first 425 laboratory-confirmed cases in Wuhan to describe the epidemiologic characteristics and transmission dynamics of NCIP.”
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia (2020, neutral): “Since then, the number of COVID-19 confirmed patients have sharply increased not only in China, but also worldwide, including Germany, South Korea, Vietnam, Singapore, Italy, and USA [1].”